1Ziv G M, Shen-Tov A G, lickman M, et al. Tilmicosin abtubacter activitv and pharmacokinetics in cows[J]. Journal of Vet, Pharmacol Terapeutics, 1995,18(5): 340-345.
2Inamoto T, Kikuchik, lijma H, et al. Antibacterial activity of timicosin against pasteurella multocida and actionobacillus pleuropeumoniae isolated from pneumonic lesions in swine[J]. J Vet Med Sci, 1994,56(5): 917-921.
1[1]Hecker, Scott J, Jefson, et al. Derivatives of 16-membered ring antibiotics[P]. US, 5545624. 1996.
2[2]Debono, Manuel, Kirst, et al. C-20-dihydro-deoxy-clicaminoderivatives of macrolide antibiotics[P]. US, 4820695. 1989.
3[3]Ziv GM,Shen-Tov AG,lickman M,et al. Tilmicosin antibacterial activity and pharmacokinetics in cows[J]. Journal of Veterinary Pharmacology & Therapeutics, 1995,18(5):340-345.
4[4]FAO. Residues of some veterinary drugs in animals and foods:Tilmicosin[DB/OL]. FAO Food and Nutrition Paper(41/9). Romeint FAO/WHO Expert Committee on Food Additives, 1996.
5[5]Thomson TD, Moran JW. Metabolism of macrolide antibiotics in cows[J]. Drugs Experimental Clinical Research, 1989,5( 1 ):47-51.
6[6]Ramadan A. Pharmacokinetics of tilmicosin in serum and milk of goats[J]. Research in Veterinary Science, 1997,62(1):48-50.
7[7]Modric S, Webb AI, Derendorf H. Pharmacokinetics and pharmacodynamics of tilmicosin in sheep and cattle[J]. Veterinary Pharmacological Therapy, 1998,21 (6):444-452.
8[8]The European Agency for the Evaluation of Medicinal Products.Veterinary Medicines Evaluation Unit:Tilmicosin, Summary Report[DB/OL]. 1996.
9[9]Chin AC, Morck DW, Merrill JK, et al. Anti-Inflammatory benefits of tilmicos in calves with Pasteurella hamlmolytica-infected lungs[J]. American Journal of Veterinary Research, 1998,59(6):765-771.
10[10]FDA. Freedom of Information Summary(NADA 140-929)[DB/OL].1996.
